Hydroxyurea Capsules Exporter from India | Genliva Wellness LLP Pharma Manufacturer

Product Overview
Key Features
Therapeutic Uses
Dosage Form Advantages

Hydroxyurea Capsules are antineoplastic medications used in the treatment of certain cancers and hematological disorders. The medicine works by inhibiting DNA synthesis, which helps slow the growth and multiplication of abnormal cells. Genliva Wellness LLP is a trusted Hydroxyurea Capsules Manufacturer in India offering high-quality oncology and hematology formulations for domestic and international pharmaceutical markets.

This formulation is widely prescribed for chronic myeloid leukemia, head and neck cancers, and various blood-related disorders. As a reliable Hydroxyurea Capsules Exporter from India, Genliva Wellness LLP supplies quality-assured pharmaceutical products to healthcare institutions and distributors worldwide.

Hydroxyurea is also recognized for its role in managing specific hematological conditions by helping reduce abnormal blood cell production and improving overall disease management.

Hydroxyurea Capsules are formulated to provide effective management of certain cancers and hematological disorders.

Contains Hydroxyurea as the active ingredient
Antineoplastic and cytoreductive agent
Inhibits DNA synthesis in rapidly dividing cells
Helps control abnormal cell proliferation
Supports hematological disorder management
Oral capsule formulation for convenient administration

Hydroxyurea Capsules are used in the treatment of various oncological and hematological conditions.

Chronic myeloid leukemia (CML)
Head and neck cancers
Essential thrombocythemia
Polycythemia vera
Sickle cell disease management
Myeloproliferative disorders

Hydroxyurea Capsules provide effective control of abnormal cell growth and blood cell production.

Helps reduce excessive blood cell formation
Slows the growth of abnormal cells
Supports long-term disease management
Improves control of hematological disorders
Provides established therapeutic efficacy
Contributes to better clinical outcomes